Brain Cancer News and Research

RSS

There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.

AI foundation model advances comprehensive brain MRI analysis

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting brain tumor mutations and predicting brain cancer survival.

5 Feb 2026

Small molecule targets glioblastoma oncogene in preclinical studies

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest brain cancer.

4 Feb 2026

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory molecule to stimulate the central nervous system (CNS) immune system after surgery to remove glioblastoma, a form of primary brain cancer.

3 Feb 2026

Researchers open ‘window to the brain’ with powerful cancer tech

Technology created at The University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.

2 Feb 2026

Researchers identify key factor to help improve treatment for glioblastoma

A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer.

30 Jan 2026

HHCM awards $566K to advance psychedelic end-of-life care research

Healing Hearts, Changing Minds (HHCM) today announced the seven awardees of Walking Each Other Home: A Fund to Promote Psychedelic Compassion for End-of-Life Care, a $566,260 philanthropic initiative supporting innovation, compassion, and dignity for people at life's end.

27 Jan 2026

Digital twin technology guides personalized treatment for brain cancer patients

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the University of Michigan, could help doctors discover which treatment strategies are most likely to be effective against individual cases of glioma.

12 Jan 2026

Unveiling IDH-mutant glioma's roots: A new path for early diagnosis

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50.

8 Jan 2026

Novel approach uncovers possible drugs based on specific cellular targets for treating glioblastoma

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor.

7 Jan 2026

New breakthrough could modernize treatment for glioblastoma

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma, a fast-growing and deadly form of brain cancer.

6 Jan 2026

Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

St. Jude Children's Research Hospital scientists identified a promising combination approach to treat a rare, but catastrophic pediatric brain cancer called atypical teratoid rhabdoid tumor (ATRT).

16 Dec 2025

New diagnostic chip enables rapid monitoring of brain cancer treatment

New diagnostic chip pulls packets released from tumor cells out of blood, showing whether cancer cells died during chemotherapy infusion.

16 Dec 2025

Researchers discover the enzyme responsible for chromothripsis in cancer

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled order, allowing cancer cells to rapidly evolve and become resistant to treatment.

11 Dec 2025

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.

8 Dec 2025

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

5 Dec 2025

Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40 percent increase in overall survival in a landmark trial of 34 patients led by University of Maryland School of Medicine (UMSOM) researchers.

24 Nov 2025

Brain Cancer News and Research

Further Reading

AI foundation model advances comprehensive brain MRI analysis

Small molecule targets glioblastoma oncogene in preclinical studies

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

Researchers open ‘window to the brain’ with powerful cancer tech

Researchers identify key factor to help improve treatment for glioblastoma

HHCM awards $566K to advance psychedelic end-of-life care research

Digital twin technology guides personalized treatment for brain cancer patients

Unveiling IDH-mutant glioma's roots: A new path for early diagnosis

Novel approach uncovers possible drugs based on specific cellular targets for treating glioblastoma

New breakthrough could modernize treatment for glioblastoma

Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

New diagnostic chip enables rapid monitoring of brain cancer treatment

Researchers discover the enzyme responsible for chromothripsis in cancer

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

Intranasal nanomedicine shows promise against glioblastoma

Engineered CAR-T cells show promise against glioblastoma in preclinical models

Focused ultrasound can be safely used in children being treated for brain cancer

New NIH grants support research on how brain fluid movement drives glioblastoma spread

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News